While no other studies have examined the effects of CA treatment on prostate cancer cell mTOR and p70 S6K, CA inhibited mTOR in hepatoma [78], lung cancer [79] and gastric cancer cells [80]. This evidence concerns the gene RPS6KB1 and prostate carcinoma.